Category : Search result: transfusiondependent thalassemia


First Oral Therapy for Thalassemia Anemia Approved by US FDA

The US FDA has approved Mitapivat (Aqvesme), the first oral treatment for anemia in adults with alpha or beta thalassemia. This breakthrough could reduce transfusion dependence, offering new hope for high-burden countries like India. Read more.

FDA Approves First Oral Thalassemia Treatment

US FDA approves Mitapivat, the first oral therapy for thalassemia anemia. Indian hematologists welcome the breakthrough but highlight access and affordability challenges in India. Read more.

Thalassemia Managed with Ayurveda & Yoga: A Case Study

A 56-year-old thalassemia patient from UP saw improved hemoglobin stability after an integrative Ayurveda and yoga program at Patanjali Wellness. Discover how holistic care complements conventional treatment.

4 Thalassemia Kids HIV+ in MP Hospital Probe

Four children with thalassemia test HIV-positive at a Satna hospital, sparking a probe into blood transfusion safety. Deputy CM vows zero tolerance for negligence. Read details.

Thalassemia survivor meets lifesaving donor in Udupi

Five-year-old thalassemia survivor Anvish Naik met his stem cell donor Ragapriya Sridhar for the first time at PHOCON conference. Their emotional reunion highlights the importance of blood stem cell donation.

HIV+ blood given to thalassemia patients in Jharkhand

In a devastating medical failure, West Singhbhum Sadar Hospital in Chaibasa transfused HIV-contaminated blood to multiple thalassemia patients, raising serious questions about blood safety protocols in India's healthcare system.

Page 1 of 1